ZNTL stock – Knox Daily

Analysts Viewpoint

Zentalis Pharmaceuticals Inc’s recent filing unveils that its Chief Medical Officer Bruns Ingmar acquired Company’s shares for reported $45656.0 on

Insiders Updates

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Stock Earnings

Zentalis Pharmaceuticals Inc’s recent filing unveils that its Chief Medical Officer Bruns Ingmar acquired Company’s shares for reported $45656.0 on

Stock Earnings

Zentalis Pharmaceuticals Inc’s filing revealed that its Chief Medical Officer Bruns Ingmar acquired Company’s shares for reported $45656.0 on Feb

Analysts Viewpoint

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Zentalis Pharmaceuticals Inc’s filing revealed that its Chief Medical Officer Bruns Ingmar acquired Company’s shares for reported $45656.0 on Feb

Insiders Updates

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Stock Earnings

Zentalis Pharmaceuticals Inc’s recently made public that its Chief Medical Officer Bruns Ingmar acquired Company’s shares for reported $45656.0 on

Tag: ZNTL stock